-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UzwneBVz/H/5AU8pUSx5hjIhBSWd5TzTNh0LWc8E/U3Zmb6Do2N52bCw+5KkH8xO uWe858bB+ovxCvv9AJH3/Q== 0000912057-02-016620.txt : 20020425 0000912057-02-016620.hdr.sgml : 20020425 ACCESSION NUMBER: 0000912057-02-016620 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020425 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SYNSORB BIOTECH INC CENTRAL INDEX KEY: 0001025863 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-52837 FILM NUMBER: 02621408 BUSINESS ADDRESS: STREET 1: STE 410 STREET 2: 1167 KENINGTON CRESCENT NW CITY: CALGARY ALBERTA CANA STATE: A0 ZIP: T2N 1X7 BUSINESS PHONE: 4032835900 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SCOUT CAPITAL CORP CENTRAL INDEX KEY: 0001164046 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 400,521 3RD AVE SW STREET 2: T2P 3T3 CITY: CALGARY STATE: A0 ZIP: 00000 BUSINESS PHONE: 4032633653 MAIL ADDRESS: STREET 1: 400,521 3RD AVE SW STREET 2: T2P 3T3 CITY: CALGARY STATE: A0 ZIP: 00000 SC 13D/A 1 a2078016zsc13da.txt SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 3) SYNSORB BIOTECH INC. (Name of Issuer) COMMON STOCK, NO PAR VALUE (Title of Class of Securities) 87160V-10-4 (CUSIP Number) GREGORY B. MATTHEWS 400,521-3RD AVENUE S.W. CALGARY, ALBERTA T2P 3T3 (403) 263-3653 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) COPY TO: WILLIAM L. BOEING HAYNES AND BOONE, LLP 1600 N. COLLINS BLVD., SUITE 2000 RICHARDSON, TEXAS 75080 (972) 680-7553 APRIL 23, 2002 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box: / / This amendment No. 3 to Schedule 13D (this "Amendment") amends and supplements the Schedule 13D filed by Scout Capital Corp. with the Securities and Exchange Commission ("SEC") on December 31, 2001 relating to the Common Stock of Synsorb Biotech Inc., as amended by Amendment No. 1 to Schedule 13D filed with the SEC on January 8, 2002 and Amendment No. 2 to Schedule 13D filed with the SEC on April 23, 2002 (as previously amended, the "Filing"). Capitalized terms used herein which are not defined herein have the meanings given to them in the Filing. The main purpose of this amendment is to restate the Common Stock holdings of Mr. Geoffrey P. Smith, which were inadvertently misstated in Amendment No. 2 to Schedule 13D. Except as set forth below, all other Items of the Filing remain unchanged. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. Item 5 is hereby amended in its entirety to read as follows: SCOUT CAPITAL CORP. (a) Number of Securities Beneficially Owned: 2,244,817 shares of Common Stock Percentage of Class: 5.6% (b) Sole Voting Power: 2,244,817 shares of Common Stock Shared Voting Power: 0 shares of Common Stock Sole Dispositive Power: 2,244,817 shares of Common Stock Shared Dispositive Power: 0 shares of Common Stock (c) The transactions made by Scout in the Common Stock in the last 60 days are detailed on Schedule A hereto, which is incorporated herein by this reference. GEOFFREY P. SMITH (a) Number of Securities Beneficially Owned: 0 shares of Common Stock Percentage of Class: 0.0% (b) Sole Voting Power: 0 shares of Common Stock Shared Voting Power: 0 shares of Common Stock Sole Dispositive Power: 0 shares of Common Stock Shared Dispositive Power: 0 shares of Common Stock (c) Mr. Smith has not conducted any transactions in the Common Stock in the last 60 days. Mr. Smith sold all of his Common Stock holdings on January 11, 2002. JIM SILYE (a) Number of Securities Beneficially Owned: 6,000 shares of Common Stock Percentage of Class: 0.0% (less than one-tenth of a percent) (b) Sole Voting Power: 6,000 shares of Common Stock Shared Voting Power: 0 shares of Common Stock Sole Dispositive Power: 6,000 shares of Common Stock Shared Dispositive Power: 0 shares of Common Stock (c) The only transaction by Mr. Silye in the Common Stock was the open market purchase of 6,000 shares of Common Stock described herein. Such purchase was conducted on February 20, 2002 at a price of (Cdn.) $ .32 per share on the Toronto Stock Exchange. SIGNATURE After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this Amendment is true, complete and correct. SCOUT CAPITAL CORP. By: /s/ David L. Tonken --------------------------------- Name: David L. Tonken Title: Chief Executive Officer Date: April 25, 2002 SCHEDULE A SCOUT TRANSACTIONS IN THE COMMON STOCK IN THE LAST 60 DAYS:
NUMBER OF PURCHASE OR DATE SHARES PRICE (CDN. $) SALE ---- ---------- -------------- ------------ 3/1/2002 9,500 .28 Purchase 3/1/2002 6,500 .285 Purchase 3/4/2002 10,000 .28 Purchase
-----END PRIVACY-ENHANCED MESSAGE-----